Dapsone
Dapsone is a prescription topical gel containing 5% dapsone, used to treat acne vulgaris in adults and adolescents. Manufactured by Cosette Pharmaceuticals, Inc., it's applied to the skin once daily. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dapsone is a prescription topical gel containing 5% dapsone, used to treat acne vulgaris in adults and adolescents. Manufactured by Cosette Pharmaceuticals, Inc., it's applied to the skin once daily. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dapsone",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dapsone — ANDA 214019 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214019"
}
]
|
| identifier | ANDA214019 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dapsone |
